Stocks
FibroGen (FGEN) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -93.2% | -116.8% | -122.6% | -201.0% | -176.9% | -55.5% | ||
| Changes by years, y/y, % | -73pp | -24pp | -6pp | -78pp | +24pp | +38.1% | |||
FibroGen. EBITDA margin, %
FibroGen. EBITDA margin, changes, pp
FibroGen (FGEN) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -141.5% | -183.6% | -49.5% | -20.0% | -26.4% | -55.5% | |
| Changes by years, y/y, % | +442pp | -2pp | +158pp | +167pp | +115pp | |||
| Changes by quarters, q/q, % | +45pp | -42pp | +134pp | +29pp | -6pp | |||
